Semaglutide Drug Profile

What is Semaglutide?

Semaglutide is a synthetic medication that belongs to a class of drugs called GLP-1 receptor agonists (glucagon-like peptide-1 receptor agonists). It is primarily prescribed for managing type 2 diabetes and has also been approved for chronic weight management in adults with obesity or overweight conditions. The medication mimics the action of a naturally occurring hormone that helps regulate blood sugar levels and appetite.

Uses

Semaglutide has several approved medical uses:

• Type 2 diabetes management: Used as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes
• Cardiovascular risk reduction: Helps reduce the risk of major cardiovascular events such as heart attack and stroke in adults with type 2 diabetes and established cardiovascular disease
• Chronic weight management: Approved for long-term weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related health condition
• Combination therapy: Often used alongside other diabetes medications like metformin when single-drug therapy is insufficient

How it works

Semaglutide works by mimicking the action of GLP-1, a hormone naturally produced in the intestines that helps regulate blood sugar levels. It stimulates insulin release when blood glucose levels are elevated, suppresses glucagon secretion (which reduces glucose production by the liver), and slows gastric emptying. Additionally, it acts on receptors in the brain to reduce appetite and food intake, contributing to its weight loss effects.

Side effects

Common side effects include:

Submit Your Paper

• Nausea
• Vomiting
• Diarrhea
• Abdominal pain
• Constipation
• Decreased appetite
• Injection site reactions (for subcutaneous forms)
• Fatigue

Serious side effects to watch for:

• Pancreatitis (severe abdominal pain that may radiate to the back)
• Severe allergic reactions (difficulty breathing, swelling of face or throat)
• Kidney problems or worsening of existing kidney disease
• Gallbladder problems including gallstones
• Severe hypoglycemia when used with insulin or sulfonylureas

Warnings and precautions

• Thyroid tumors: May increase the risk of thyroid C-cell tumors; contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
• Pregnancy and breastfeeding: Should be discontinued at least 2 months before planned pregnancy; safety during breastfeeding is not established
• Kidney impairment: Use with caution in patients with kidney disease, as gastrointestinal side effects may worsen kidney function
• Diabetic retinopathy: Rapid improvement in blood sugar control may temporarily worsen diabetic eye disease
• Pancreatitis history: Use with extreme caution in patients with a history of pancreatitis

Interactions

• Insulin and sulfonylureas: Increased risk of hypoglycemia; dosage adjustments may be necessary
• Oral medications: May delay absorption of oral drugs due to delayed gastric emptying; take oral medications at least 1 hour before semaglutide
• Warfarin: May affect INR levels; monitor anticoagulation closely
• Digoxin: Potential for altered absorption; monitor digoxin levels
• Oral contraceptives: May reduce effectiveness due to delayed gastric emptying; consider alternative contraceptive methods
• Levothyroxine: May affect absorption; monitor thyroid function tests
• Antibiotics: Timing of administration may be affected; consult healthcare provider
• Pain medications: Delayed gastric emptying may affect absorption of oral pain relievers

Check interactions with the GMJ Interaction Checker

Dosage

For type 2 diabetes, the typical starting dose is 0.25 mg once weekly by subcutaneous injection, gradually increased to 0.5 mg weekly after 4 weeks, with a maximum dose of 1 mg weekly if needed. For weight management, dosing starts at 0.25 mg weekly and is gradually escalated over 16-20 weeks to a maintenance dose of 2.4 mg weekly. An oral formulation is available starting at 3 mg daily, potentially increasing to 7 mg or 14 mg daily. Dosage adjustments should always be made under medical supervision, and individual dosing may vary based on patient response, tolerability, and other health conditions. Always consult your healthcare provider for appropriate dosing recommendations.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).